AstraZeneca (AZN) News Today £105.26 +108.00 (+1.04%) As of 08:26 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period AstraZeneca climbs Friday, outperforms marketMay 16, 2025 | marketwatch.comIs AstraZeneca (AZN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?May 13, 2025 | msn.comBrokerages Set AstraZeneca PLC (LON:AZN) Target Price at GBX 6,303.50May 13, 2025 | americanbankingnews.comWhy did the AstraZeneca share price just fall, and what should we do?May 12, 2025 | msn.comAstraZeneca PLC (LON:AZN) Given Average Rating of "Moderate Buy" by BrokeragesAstraZeneca PLC (LON:AZN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six analysts that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendatioMay 12, 2025 | marketbeat.comAstraZeneca Reports Positive Data From Cancer Drug Trial: Retail Sentiment BrightensMay 9, 2025 | msn.comAstraZeneca advances Friday, outperforms marketMay 9, 2025 | marketwatch.comAstraZeneca slides Wednesday, underperforms marketMay 7, 2025 | marketwatch.comAstraZeneca Gets Approval For Oncology Drug To Treat Mantle Cell Lymphoma In EU: But Retail Sentiment DipsMay 6, 2025 | msn.comAstraZeneca (LSE:AZN) Announces Positive Results From Breztri Trials For Uncontrolled AsthmaMay 2, 2025 | finance.yahoo.comAstraZeneca’s Breztri Therapy Meets Primary Goals In Late-Stage Trials To Treat Asthma: Retail’s PositiveMay 2, 2025 | msn.comShore Capital Reiterates Buy Rating for AstraZeneca (LON:AZN)Shore Capital reissued a "buy" rating on shares of AstraZeneca in a research note on Tuesday.May 1, 2025 | marketbeat.comAstraZeneca (LSE:AZN) Reports Higher Earnings, Dividend Increase, and Clinical Trial DiscontinuationApril 29, 2025 | uk.finance.yahoo.comFTSE 100 Live: Stocks start in stalemate as AstraZeneca and BP disappoint, Entain impressesApril 29, 2025 | uk.investing.comAstraZeneca shares fall as revenue miss tempers strong Q1 earningsApril 29, 2025 | za.investing.comFTSE today: stocks flat as HSBC, BP, AstraZeneca post resultsApril 29, 2025 | investing.comAstraZeneca warns of potential additional tax penalties in ChinaApril 29, 2025 | msn.comObesity drug boom has a new pecking orderApril 25, 2025 | reuters.comTempus AI announces oncology collaboration with AstraZeneca, Pathos AIApril 23, 2025 | markets.businessinsider.comBTIG says AstraZeneca deal demonstrates value of Tempus AI data AI businessApril 23, 2025 | markets.businessinsider.comAstraZeneca announces results from analysis of DESTINY-Breast09 trialApril 21, 2025 | markets.businessinsider.comAstraZeneca's Enhertu, pertuzumab combo improves breast cancer treatment in trialApril 21, 2025 | msn.comAstraZeneca (LSE:AZN) and Daiichi Sankyo's ENHERTU Shows Promising Results in HER2 Breast Cancer TrialApril 21, 2025 | finance.yahoo.comAstraZeneca slides Thursday, underperforms marketApril 17, 2025 | marketwatch.comAstraZeneca unit sued over alleged monopoly on blockbuster drug SolirisApril 17, 2025 | reuters.comAstraZeneca PLC (LON:AZN) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAstraZeneca PLC (LON:AZN - Get Free Report) has earned an average recommendation of "Moderate Buy" from the six ratings firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendaApril 16, 2025 | marketbeat.comIs AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?April 15, 2025 | msn.comIs AstraZeneca (AZN) The Best UK Stock to Buy According to Billionaires?April 14, 2025 | msn.comAstraZeneca PLC: Result of AGMApril 12, 2025 | finanznachrichten.dePharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & MoreApril 11, 2025 | msn.comAstraZeneca (LON:AZN) Reaches New 52-Week Low - What's Next?AstraZeneca (LON:AZN) Reaches New 12-Month Low - What's Next?April 11, 2025 | marketbeat.comDown 28% in 8 months, is AstraZeneca’s share price too cheap for me to pass up right now?April 10, 2025 | uk.finance.yahoo.comAstrazeneca (AZN) Stock Moves -1.35%: What You Should KnowApril 8, 2025 | msn.comAstraZeneca (LON:AZN) Stock Price Passes Above 200-Day Moving Average - Time to Sell?AstraZeneca (LON:AZN) Stock Price Crosses Above 200-Day Moving Average - Should You Sell?April 5, 2025 | marketbeat.comDaiichi Sankyo, AstraZeneca’s Enhertu approved in European UnionApril 4, 2025 | markets.businessinsider.comAstraZeneca’s Imfinzi combination with chemo approved in EU to treat NSCLCApril 4, 2025 | markets.businessinsider.comPharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits FailureApril 4, 2025 | msn.comAstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?April 4, 2025 | finance.yahoo.comBernstein Sticks to Their Buy Rating for AstraZeneca (AZN)April 3, 2025 | markets.businessinsider.comLive Nasdaq Composite: FIVE Falls, AZN and PEP Rise From Tariff AshesApril 3, 2025 | msn.comAstraZeneca says AZD0780 demonstrates significant LDL-C reduction in trialMarch 31, 2025 | markets.businessinsider.comAstraZeneca announces FDA approval of Imfinzi combinationMarch 31, 2025 | markets.businessinsider.comBerenberg Bank Reaffirms "Buy" Rating for AstraZeneca (LON:AZN)Berenberg Bank restated a "buy" rating and issued a GBX 140 ($1.80) price objective on shares of AstraZeneca in a research report on Wednesday.March 28, 2025 | marketbeat.comJ.P. Morgan Sticks to Their Buy Rating for AstraZeneca (AZN)March 27, 2025 | markets.businessinsider.comAstrazeneca (AZN) Stock Moves -0.45%: What You Should KnowMarch 27, 2025 | msn.comChina on track to outpace Europe in pharmaceutical innovation, says AstraZeneca CEOMarch 26, 2025 | za.investing.comAstraZeneca announces results presented at ELCC on TagrissoMarch 26, 2025 | markets.businessinsider.comAstraZeneca slips Monday, underperforms marketMarch 24, 2025 | marketwatch.comPrediction: 12 months from now, AstraZeneca’s share price could be…March 24, 2025 | msn.comAstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandalsMarch 22, 2025 | msn.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.330.65▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼23▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Ithaca Energy News HUTCHMED News Grainger News Indivior News Bloomsbury Publishing News Origin Enterprises News Global Ports News India Capital Growth News Alpha Real Trust News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AZN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts